Analysis of the efficacy and tolerability of gefitinib ('Iressa', ZD1839) in previously treated patients with non-small-cell lung cancer enrolled in the 'Iressa' Expanded Access Program

K. De Leeuw, Denis Schallier, Erika Sermijn, C. Fontaine, Bart Neyns, Ines Samyn, Jacques De Greve

Research output: Contribution to specialist/vulgarizing publicationArticleVulgarizing

Original languageEnglish
Specialist publicationUnknown Journal
Publication statusPublished - 2003

Bibliographical note

Br.J. Cancer.89:S28-S28 S2 dec 2003

Cite this